Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease

European Journal of Gastroenterology and Hepatology

Volumn 8, Issue 3, 1996, Pages 229-233

  Florent, Christian ^a,i   Cortot, Antoine ^b   Quandale, Pierre ^b   Sahmoud, Tarek ^a   Modigliani, Robert ^c   Sarfaty, Emile ^c   Valleur, Patrice ^c   Dupas, Jean Louis ^d   Daurat, Marc ^d   Faucheron, Jean Luc ^a   Lerebours, Eric ^e   Michot, Francis ^e   Belaiche, Jacques ^f   Jacquet, Nicolas ^f   Soulé, Jean Claude ^g   Rothman, Nelly ^g   Gendre, Jean Pierre ^h   Malafosse, Michel ^h  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIV LILLE   (France)

^c University of Paris   (France)

^d AMIENS UNIVERSITY HOSPITAL   (France)

^e HÔPITAL CHARLES NICOLLE   (France)

^f UNIVERSITY OF LIÈGE   (Belgium)

^g HÔPITAL LOUIS MOURIER   (France)

^h HÔPITAL ROTHSCHILD   (France)

ⁱ HÔPITAL SAINT ANTOINE   (France)

Author keywords

Crohn's disease; Mesalazine; Postoperative recurrences

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; MESALAZINE; METRONIDAZOLE; PLACEBO;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COLON RESECTION; COLON ULCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DIARRHEA; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; ILEUM RESECTION; INTESTINE STENOSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE;

EID: 9244235034     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199603000-00008     Document Type: Article

References (24)

1. De Dombal FT, Burton I, Goligher JC: Recurrence of Crohn's disease after primary excisional surgery. Gut 1971, 12:519-527.
2. Goligher JC: Inflammatory disease of the bowel. Result of resection for Crohn's disease. Dis Colon Rectum 1976, 19:584-587.
3. Greenstein AJ, Lachman P, Sachar DB, et al.: Perforating and non perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut 1988, 29:588-592.
4. Hellers G: Crohn's disease in Stockholm county 1955-1974. A study of epidemiology. Results of surgical treatment and long-terms prognosis. Acta Chir Scand 1979, Suppl 490:31-48.
5. Mekhjian HS, Switz DM, Watts HD, Derne JJ, Katon RM, Beman FM: National Cooperative Crohn's Disease Study: factors determining recurrence of Crohn's disease after surgery. Gastroenterology 1979, 77:907-913.
6. Sachar DB, Wolfson OM, Greenstein AJ, Goldberg J, Styczynski R, Janowitz HD: Risk factors for post operative recurrence of Crohn's disease. Gastroenterology 1983, 85:917-921.
7. Whelan G, Farmer RG, Fazio VW, Goormastic M: Recurrence after surgery in Crohn's disease. Gastroenterology 1985; 88:1826-1833.
8. Farmer RG, Hawk WA, Turnball RB: Clinical patterns in Crohn's disease. A statistical study of 615 cases. Gastroenterology 1975, 68:627-635.
9. Geboes K, Rutgeerts P, Vantrappen G, Kerremans R: Early lesions in the neoterminal ileum after Crohn's resection do not originate from identifiable microscopic inflammation. Gastroenterology 1986, 80:1424.
10. Koch TR, Cave DR, Ford H, Kirsner JB: Crohn's ileitis and ileocolitis. A study of anatomical distribution of recurrence. Dig Dis Sci 1981, 26:528-531.
11. Olaison G, Smedh K, Sjodahl R: Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers, preceding symptoms. Gut 1992, 33:331-335.
12. Rutgeerts P, Geboes K, Vantrappen G, Kerremans R, Coenegrachts JL, Coremans G: Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut 1984, 25:665-672.
13. Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M: Predictability of the postoperative course of Crohn's disease. Gastroenterology 1990, 99:956-963.
14. International Mesalazine Study Group: Coated oral 5-aminosalicylic acid versus placebo in maintaining remission of inactive Crohn's disease. Aliment Pharmacol Ther 1990, 4:55-64.
15. Singleton J, Gitnick G, Hanauer S, et al.: Reponse of Crohn's disease to oral Pentasa® (controlled release mesalazine) as a function of disease location and prior therapy: results of a multicenter study. Gastroenterology 1991, 100:A251.
16. Gendre JP, Mary JY, Florent C, et al.: Oral mesalazine (Pentasa®) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. Gastroenterology 1993, 104:435-439.
17. Best WR, Becktel JM, Singleton JW: Rederived values of the eight coefficients of the Crohn's disease activity index (CDAI). Gastroenterology 1979, 77:843-846.
18. Modigliani R, Mary JY, Simon JF, et al.: Clinical, biological, and endoscopic pictures of attacks of Crohn's disease. Evolution on prednisolone. Gastroenterology 1990, 98:811-818.
19. Landi B, Nguyen Anh A, Cortot A and the Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives: Endoscopic monitoring of Crohn's disease treatment: a prospective randomized clinical trial. Gastroenterology 1992, 102:1647-1653.
20. Dupont WD, Plummer WD: Power and sample size calculations: a review and computer program. Com Clin Trials 1990, 11:116-128.
21. Hanauer S, Belker M, Gitnick C, et al.: Multi-center, placebo-controlled, dose-ranging study of oral Pentasa® (controlled-release mesalazine) for active Crohn's disease: preliminary results. Gastroenterology 1990, 98:A173.
22. Caprilli R, Andreoli A, Capurso L, et al.: Oral mesalazine (5-aminosalicylic acid: Asacol) for the prevention of post-operative recurrence of Crohn's disease. Aliment Pharmacol Ther 1994, 8:35-43.
23. Rutgeerts P, Peeters M, Hiele M, et al.: A placebo controlled trial of metronidazole for recurrence prevention of Crohn's disease after resection of the terminal ileum. Gastroenterology 1992, 102:A688.
24. Sutherland L.R, Ramcharan S, Bryant H, Fick C: Effects of cigarette smoking on recurrence of Crohn's disease. Gastroenterology 1990, 98:1123-1128.